Junmei Jia

676 total citations
30 papers, 336 citations indexed

About

Junmei Jia is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Junmei Jia has authored 30 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Junmei Jia's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Junmei Jia is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Junmei Jia collaborates with scholars based in China and Singapore. Junmei Jia's co-authors include Yarong Guo, Ping Mei, Chenan Liu, Sanyuan Zhang, Xinyan Wang, Yi Yan, Longfeng Zhao, Shoude Zhang, Wei Li and Xin Yan and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Medicine.

In The Last Decade

Junmei Jia

28 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junmei Jia China 13 182 96 83 53 44 30 336
Andrea Clarke United States 8 166 0.9× 80 0.8× 73 0.9× 32 0.6× 56 1.3× 17 368
Mary E. Irwin United States 9 287 1.6× 88 0.9× 115 1.4× 45 0.8× 60 1.4× 11 457
Jiong Yang China 9 244 1.3× 132 1.4× 81 1.0× 46 0.9× 60 1.4× 14 415
Jennifer R. Bethard United States 12 262 1.4× 87 0.9× 60 0.7× 40 0.8× 57 1.3× 24 467
Yuhong Sun China 11 177 1.0× 86 0.9× 140 1.7× 99 1.9× 42 1.0× 23 421
Virginie Quidville France 8 228 1.3× 129 1.3× 88 1.1× 42 0.8× 44 1.0× 10 398
Joshua Ogony United States 9 178 1.0× 77 0.8× 108 1.3× 74 1.4× 41 0.9× 14 357
Huo Wu China 12 233 1.3× 89 0.9× 82 1.0× 53 1.0× 22 0.5× 16 439
Mailin Li United States 9 188 1.0× 81 0.8× 57 0.7× 92 1.7× 25 0.6× 12 335

Countries citing papers authored by Junmei Jia

Since Specialization
Citations

This map shows the geographic impact of Junmei Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junmei Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junmei Jia more than expected).

Fields of papers citing papers by Junmei Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junmei Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junmei Jia. The network helps show where Junmei Jia may publish in the future.

Co-authorship network of co-authors of Junmei Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Junmei Jia. A scholar is included among the top collaborators of Junmei Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junmei Jia. Junmei Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Lili, Tao Zhang, Cheng‐Gong Liao, et al.. (2023). Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial. International Journal of Hyperthermia. 40(1). 2241689–2241689. 1 indexed citations
2.
Yan, Xin, et al.. (2022). Total Parenteral Nutrition Treatment Improves the Nutrition Status of Gynecological Cancer Patients by Improving Serum Albumin Level. Frontiers in Medicine. 8. 759387–759387. 10 indexed citations
3.
Yan, Xin, et al.. (2022). Exosomal MiR-423–3p inhibits macrophage M2 polarization to suppress the malignant progression of cervical cancer. Pathology - Research and Practice. 235. 153882–153882. 24 indexed citations
4.
Yan, Yi, Xinyan Wang, Chenan Liu, & Junmei Jia. (2022). Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study. BMC Pulmonary Medicine. 22(1). 166–166. 20 indexed citations
5.
Mei, Ping, et al.. (2021). TRIM21 improves apatinib treatment in gastric cancer through suppressing EZH1 stability. Biochemical and Biophysical Research Communications. 586. 177–184. 23 indexed citations
6.
Guo, Yarong, et al.. (2021). KLF7/VPS35 axis contributes to hepatocellular carcinoma progression through CCDC85C-activated β-catenin pathway. Cell & Bioscience. 11(1). 73–73. 28 indexed citations
8.
Guo, Yarong, Na Zhu, Junmei Jia, et al.. (2021). Pleckstrin 2 is a potential drug target for colorectal carcinoma with activation of APC/β‑catenin. Molecular Medicine Reports. 24(6). 5 indexed citations
9.
Mei, Ping, Shumin Wang, Yan Chen, & Junmei Jia. (2021). The Short Non-Coding RNA 1251-5p Regulates Stemness Transformation and Inhibits Aggression of Lung Malignant Tumor Cells. Journal of Biomaterials and Tissue Engineering. 11(5). 982–989. 1 indexed citations
10.
Mei, Ping, et al.. (2020). Exosomal CircPRRX1 Enhances Doxorubicin Resistance in Gastric Cancer by Regulating MiR-3064-5p/PTPN14 Signaling. Yonsei Medical Journal. 61(9). 750–750. 28 indexed citations
11.
Zhang, Shoude, Qiang Gao, Wei Li, et al.. (2019). Shikonin inhibits cancer cell cycling by targeting Cdc25s. BMC Cancer. 19(1). 20–20. 37 indexed citations
12.
Guo, Yarong, et al.. (2019). The prognostic value of homeobox B7 expression in patients with hepatocellular carcinoma.. PubMed. 12(7). 2682–2690. 1 indexed citations
13.
Deng, Qiuhua, Yuan Qiu, Junmei Jia, et al.. (2019). Genetic alteration profile of EGFR-mutant resected IIB–IIIA stage NSCLC and correlation to clinical outcomes. Translational Lung Cancer Research. 8(6). 838–846. 5 indexed citations
15.
Wu, Meng, Junmei Jia, Wenting Cao, et al.. (2018). The role of the Patient-Generated Subjective Global Assessment (PG-SGA) and biochemical markers in predicting anemia patients with cancer. Supportive Care in Cancer. 27(4). 1443–1448. 6 indexed citations
16.
Zhu, Guoqiang, Huihong Zhai, Junmei Jia, et al.. (2018). Simultaneous stimulation with tumor necrosis factor-α and transforming growth factor-β1 induces epithelial-mesenchymal transition in colon cancer cells via the NF-κB pathway. Oncology Letters. 15(5). 6873–6880. 12 indexed citations
17.
Shi, Ruyi, Xun Huang, Xiao Hu, et al.. (2016). Artesunate attenuates glioma proliferation, migration and invasion by affecting cellular mechanical properties. Oncology Reports. 36(2). 984–990. 26 indexed citations
18.
Wang, Xuekai, et al.. (2010). Label-free Colorimetric Assay Based on Gold Nanoparticles in Detection of NOS1AP with Single Nucleotide Polymorphism. Gaodeng xuexiao huaxue xuebao. 31(10). 1965. 1 indexed citations
19.
Han, Lianyi, et al.. (2008). Trends in the Exploration of Anticancer Targets and Strategies in Enhancing the Efficacy of Drug Targeting. Current Molecular Pharmacology. 1(3). 213–232. 27 indexed citations
20.
Zhao, Longfeng, et al.. (2004). [The role of enterogenous endotoxemia in the pathogenesis of non-alcoholic steatohepatitis].. PubMed. 12(10). 632–632. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026